Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease

被引：0
|
作者：
Lingor, P.
Leha, A.
Michalke, B.
Boerger, M.
Baehr, M.
Zerr, I.
Maass, F.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1444
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
    Willkommen, Desiree
    Lucio, Marianna
    Moritz, Franco
    Forcisi, Sara
    Kanawati, Basem
    Smirnov, Kirill S.
    Schroeter, Michael
    Sigaroudi, Ali
    Schmitt-Kopplin, Philippe
    Michalke, Bernhard
    PLOS ONE, 2018, 13 (12):
  • [22] Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid
    Winchester, Laura
    Barber, Imelda
    Lawton, Michael
    Ash, Jessica
    Liu, Benjamine
    Evetts, Samuel
    Hopkins-Jones, Lucinda
    Lewis, Suppalak
    Bresner, Catherine
    Malpartida, Ana Belen
    Williams, Nigel
    Gentlemen, Steve
    Wade-Martins, Richard
    Ryan, Brent
    Holgado-Nevado, Alejo
    Hu, Michele
    Ben-Shlomo, Yoav
    Grosset, Donald
    Lovestone, Simon
    BRAIN COMMUNICATIONS, 2022, 5 (01)
  • [23] Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
    Kang, Un Jung
    Boehme, Amelia K.
    Fairfoul, Graham
    Shahnawaz, Mohammad
    Ma, Thong Chi
    Hutten, Samantha J.
    Green, Alison
    Soto, Claudio
    MOVEMENT DISORDERS, 2019, 34 (04) : 536 - 544
  • [24] Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis
    dos Santos, Marcia Cristina T.
    Scheller, Dieter
    Schulte, Claudia
    Mesa, Irene R.
    Colman, Peter
    Bujac, Sarah R.
    Bell, Rosie
    Berteau, Caroline
    Perez, Luis Tosar
    Lachmann, Ingolf
    Berg, Daniela
    Maetzler, Walter
    da Costa, Andre Nogueira
    PLOS ONE, 2018, 13 (11):
  • [25] β-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease
    Andreasen, N
    Blennow, K
    PEPTIDES, 2002, 23 (07) : 1205 - 1214
  • [26] Recent cerebrospinal fluid biomarker studies of Alzheimer's disease
    Choi, Yong Seok
    Choe, Leila H.
    Lee, Kelvin H.
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (06) : 919 - 926
  • [27] Cerebrospinal fluid α-synuclein as a potential biomarker for Alzheimer's disease
    Li, JieQiong
    Yu, Jintai
    Tan, Lan
    NEUROLOGY, 2018, 90
  • [28] β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
    Bing Xu
    Kang Xiao
    Xiaoxi Jia
    Rundong Cao
    Donglin Liang
    Ruhan A
    Weiwei Zhang
    Chunjie Li
    Liping Gao
    Cao Chen
    Qi Shi
    Xiaoping Dong
    Alzheimer's Research & Therapy, 17 (1)
  • [29] Elemental profiles as biomarkers for diagnosis and disease progression of Parkinson's disease
    Maass, F.
    Boerger, M.
    Fischbach, A.
    Michalke, B.
    Baehr, M.
    Zerr, I.
    Lingor, P.
    MOVEMENT DISORDERS, 2016, 31 : S610 - S610
  • [30] Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease
    Jiménez-Jiménez, FJ
    Molina, JA
    Hernánz, A
    Fernández-Vivancos, E
    de Bustos, F
    Barcenilla, B
    Gómez-Escalonilla, C
    Zurdo, M
    Berbel, A
    Villanueva, C
    NEUROSCIENCE LETTERS, 1999, 271 (01) : 33 - 36
12345